Covered recipient · General Payments record
NICHOLAS RAND NORTON
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,943.92
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,004.25 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BIOTISSUE HOLDINGS INC. | $345.74 | 4 |
| ABBVIE INC. | $188.39 | 11 |
| Alcon Laboratories Inc | $146.39 | 4 |
| Genentech USA, Inc. | $120.14 | 1 |
| Apellis Pharmaceuticals, Inc. | $104.75 | 1 |
| RxSight Inc | $24.34 | 1 |
| Sight Sciences, Inc. | $21.95 | 1 |
| Dompe US, Inc. | $19.44 | 1 |
| Tarsus Pharmaceuticals, Inc. | $16.88 | 1 |
| Mallinckrodt Hospital Products Inc. | $16.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.38 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134006 | CMS |
| ABBVIE INC. | $26.17 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134008 | CMS |
| ABBVIE INC. | $13.42 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134010 | CMS |
| ABBVIE INC. | $14.11 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134012 | CMS |
| ABBVIE INC. | $23.21 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134014 | CMS |
| ABBVIE INC. | $22.56 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134016 | CMS |
| ABBVIE INC. | $21.53 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134018 | CMS |
| ABBVIE INC. | $25.78 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134020 | CMS |
| ABBVIE INC. | $15.16 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134022 | CMS |
| ABBVIE INC. | $10.89 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134024 | CMS |
| ABBVIE INC. | $5.18 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105134026 | CMS |
| Alcon Vision LLC | $22.05 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110673513 | CMS |
| Alcon Vision LLC | $16.39 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110673511 | CMS |
| Alcon Vision LLC | $6.09 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110673509 | CMS |
| Alcon Vision LLC | $101.86 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110673515 | CMS |
| Apellis Pharmaceuticals, Inc. | $104.75 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154027193 | CMS |
| BIOTISSUE HOLDINGS INC. | $12.50 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148786343 | CMS |
| BIOTISSUE HOLDINGS INC. | $160.37 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148786387 | CMS |
| BIOTISSUE HOLDINGS INC. | $12.50 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148754424 | CMS |
| BIOTISSUE HOLDINGS INC. | $160.37 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148787566 | CMS |
| Dompe US, Inc. | $19.44 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151412617 | CMS |
| Genentech USA, Inc. | $120.14 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133080967 | CMS |
| Mallinckrodt Hospital Products Inc. | $16.23 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145113918 | CMS |
| RxSight Inc | $24.34 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144223787 | CMS |
| Sight Sciences, Inc. | $21.95 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151929467 | CMS |
| Tarsus Pharmaceuticals, Inc. | $16.88 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139121244 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.